PubMed Health⌕ Search

Biomedical subjects

E Gangitano

Publications and source records attributed to E Gangitano.

6 recordsLinked to original sources
PubMed1992

Congenital pulmonary alveolar proteinosis: failure of treatment with extracorporeal life support.

Pulmonary alveolar proteinosis, a rare disease in neonates, is characterized by the accumulation of insoluble amorphous material within the alveoli. We describe two pairs of siblings with pulmonary alveolar proteinosis in two otherwise unaffected families. All four patients were term neonates in whom severe pulmonary failure developed within hours after birth; three had mature lung profiles. Radiographic lung markings were characterized by an early granular pattern followed by lung opacification. All patients were treated with extracorporeal life support for periods of 212 to 381 hours, but none survived. Life spans ranged from 16 to 190 days. We speculate that pulmonary alveolar proteinosis in neonates results from a genetic defect in surfactant processing that may not be amenable to conventional or unconventional therapies, including extracorporeal life support.

Extracorporeal Membrane Oxygenation↗
PubMed1990

Ventilation parameters and arterial blood gases as a prediction of hypoplasia in congenital diaphragmatic hernia.

Attempts to predict the degree of pulmonary hypoplasia associated with congenital diaphragmatic hernia have been made by evaluating the ventilation parameters and the arterial blood gasses of these patients. A CO2 index as a predictor of outcome, which correlates the PaCO2 with the ventilation index, was recently proposed. However, in this study the postductal PaO2 was a better predictor of survival. And the so-called "honeymoon period" was a better indicator of the efficacy of extracorporeal membrane oxygenation (ECMO) than the CO2 index. Nineteen patients were evaluated; 11 were treated with ECMO, and eight were not considered suitable for ECMO.

Airway Resistance↗
PubMed1990

Oxygenation index in patients with meconium aspiration: conventional and extracorporeal membrane oxygenation therapy.

The use of the alveolar-arterial oxygen difference P(A-a)O2 and the oxygenation index (mean airway pressure [Paw] FIO2 x 100/PaO2) have been proposed for selecting infants who will require extracorporeal membrane oxygenation (ECMO) therapy. However, the use of the oxygenation index (OI) in conjunction with Paw in an exclusive population of patients with meconium aspiration syndrome (MAS) has not been reported. Fourteen patients born in our facility and managed with conventional therapy and five infants treated with ECMO were enrolled in the study. All patients had clinical and x-ray evidence of MAS. Infants who received conventional treatment required mechanical ventilation greater than 48 h, FIO2 1.0, and were under the care and supervision of one neonatologist. Management was directed to minimize barotrauma by avoidance of routine hyperventilation, use of lower Paw, and sufficient expiratory time. One patient died before ECMO and 13 infants survived. Six survivors had an OI greater than 25 (three had an OI greater than 40), six had a Paw greater than or equal to 12 cm H2O (12 to 15 cm H2O in five infants) and six patients had a P(A-a)O2 greater than or equal to 610 torr. One surviving infant was transferred for ECMO therapy (OI 67, Paw 20 cm H2O). The five patients treated with ECMO survived (OI 48 to 92, Paw 20 to 29.5 cm H2O P(A-a)O2 627 to 650 torr). One patient in each group developed chronic lung disease with evidence of resting tachypnea. Our findings indicate that an OI greater than 40 in association with a Paw greater than or equal to 20 cm H2O may be helpful in predicting which infants with MAS need ECMO, whereas patients requiring a Paw less than or equal to 15 cm H2O can be managed with conventional therapy. An OI greater than or equal to 25 but less than 40 is not associated with high mortality in these patients. The predictive value of Paw of 16 to 20 cm H2O and the duration of an OI greater than 40 in patients with MAS need further investigation.

Airway Resistance↗
PubMed1989

Color Doppler imaging of intracranial vessels in the neonate.

This study was performed to examine the effectiveness of color Doppler imaging (CDI) in demonstrating the neonatal intracranial vessels and altered intracranial flow patterns and to determine the optimal approach in imaging and intracranial vasculature. The study was conducted in two parts. First, 14 neonates were examined with CDI by using a standard approach through the anterior fontanel. Whenever possible, views through the posterior fontanel and the temporal bone were obtained also. The anterior cerebral, M1 segment of the middle cerebral, distal internal carotid, and basilar arteries were demonstrated consistently. Portions of the vertebral distal middle cerebral, and posterior cerebral arteries were frequently visualized. In the second part of the study, we examined 10 neonates who had undergone extracorporeal membrane oxygenation. In this group of patients, CDI was able to demonstrate occlusion of the right internal carotid artery and the reversal of flow through the ipsilateral A1 segment. Increased flow on the contralateral side and in the basilar artery was observed in several patients. The anterior fontanel approach was shown to be the most useful in identifying most of the major intracranial arteries and veins with CDI. In addition, the body weights and gestational ages of the neonates were found to significantly influence the success rate in visualizing the intracranial vasculature.

Basilar Artery↗
PubMed1988

Clinical use of extracorporeal membrane oxygenation in the treatment of persistent pulmonary hypertension following surgical repair of congenital diaphragmatic hernia.

The clinical use of extracorporeal membrane oxygenation (ECMO) in the treatment of persistent pulmonary hypertension following surgical repair of congenital diaphragmatic hernia is reported on 11 patients. The patients had a total of 13 treatments; two patients had two treatments. During the same period of clinical use, 122 patients were placed on ECMO for all causes. The indications, results, and complications of the use of ECMO for treatment following surgical repair of congenital diaphragmatic hernia are presented. The reversal of persistent pulmonary hypertension is demonstrated. All patients treated by ECMO for congenital diaphragmatic hernia have survived.

Extracorporeal Membrane Oxygenation↗